| Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 |
|---|---|---|---|---|---|
Gross Sales | 6,522.04 | 6,623.8 | 5,476.3 | 6,159.16 | 6,021.12 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 6,522.04 | 6,623.8 | 5,476.3 | 6,159.16 | 6,021.12 |
Other Operating Income | 121.72 | 54.18 | 93.36 | 84.29 | 79.58 |
Other Income | 42.81 | 70.91 | 1,215.9 | 21.42 | 495.1 |
Total Income | 6,686.57 | 6,748.89 | 6,785.56 | 6,264.86 | 6,595.79 |
Total Expenditure | 5,855.32 | 5,487.86 | 5,797.47 | 5,721.25 | 5,994.6 |
PBIDT | 831.25 | 1,261.03 | 988.09 | 543.61 | 601.19 |
Interest | 119 | 88.06 | 282.9 | 233.07 | 206.24 |
PBDT | 712.25 | 1,172.97 | 705.19 | 310.54 | 394.95 |
Depreciation | 247.94 | 238.07 | 298.41 | 283.49 | 286.53 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 99.55 | 282.79 | 1,290.29 | -174.74 | 451.84 |
Deferred Tax | 12.34 | -42.61 | 661.57 | 90.22 | -231.04 |
Reported Profit After Tax | 352.42 | 694.72 | -1,545.09 | 111.57 | -112.38 |
Minority Interest After NP | -0.2 | 0.24 | 24.57 | 43.58 | 43.35 |
Net Profit after Minority Interest | 352.62 | 694.48 | -1,569.66 | 67.99 | -155.73 |
Extra-ordinary Items | -372.82 | 0 | -126.18 | -287.23 | -298.89 |
Adjusted Profit After Extra-ordinary item | 725.44 | 694.48 | -1,443.48 | 355.22 | 143.16 |
EPS (Unit Curr.) | 12.5 | 24.61 | 0 | -6.6 | 0 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 12.74 | 19.03 | 18.04 | 8.82 | 9.98 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 5.4 | 10.48 | -28.21 | 1.81 | -1.86 |
Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.
At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.
Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.
Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.
The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.
Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.
ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.
The reshuffle comes after VS Mani, the company's current chief, announced early retirement; he will officially retire as chief on May 26, 2025 after an eight-year career with the company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
